المؤلفون: Miyake M; Department of Urology, Nara Medical University, Kashihara, Japan., Nishimura N; Department of Urology, Nara Medical University, Kashihara, Japan., Nakahama T; Department of Urology, Nara Medical University, Kashihara, Japan., Nishimoto K; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Oyama M; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Matsushita Y; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Miyake H; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Fukuhara H; Department of Urology, Kochi Medical School, Nankoku, Japan., Inoue K; Department of Urology, Kochi Medical School, Nankoku, Japan., Kobayashi K; Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan., Matsuyama H; Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan.; Department of Urology, JA Yamaguchi Kouseiren Nagato General Hospital, Nagato, Japan., Fujii T; Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan.; Division of Fostering Required Medical Human Resources, Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka, Japan., Hirao Y; Department of Urology, Osaka Gyoumeikan Hospital, Konohana-ku, Japan., Fujimoto K; Department of Urology, Nara Medical University, Kashihara, Japan.

المصدر: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Aug; Vol. 31 (8), pp. 876-885. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Cystectomy*/methods , Neoplasm Recurrence, Local*/epidemiology , Neoplasm Recurrence, Local*/prevention & control , Non-Muscle Invasive Bladder Neoplasms*/mortality , Non-Muscle Invasive Bladder Neoplasms*/pathology , Non-Muscle Invasive Bladder Neoplasms*/surgery, Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Disease Progression ; Neoplasm Invasiveness ; Neoplasm, Residual ; Progression-Free Survival ; Propensity Score ; Reoperation/statistics & numerical data ; Retrospective Studies ; Urinary Bladder/pathology ; Urinary Bladder/surgery

المؤلفون: Balboa-Barreiro V; Universidade da Coruña, Rheumatology and Health Research Group, Department of Health Sciences, Faculty of Nursing and Podiatry, Esteiro, 15403 Ferrol, Spain; Instituto de Investigación Biomédica de A Coruña (INIBIC), Nursing and Health Care Research Group, Xubias de Arriba 84, 15006 A Coruña, Spain., Pértega-Díaz S; Universidade da Coruña, Rheumatology and Health Research Group, Department of Health Sciences, Faculty of Nursing and Podiatry, Esteiro, 15403 Ferrol, Spain; Instituto de Investigación Biomédica de A Coruña (INIBIC), Nursing and Health Care Research Group, Xubias de Arriba 84, 15006 A Coruña, Spain. Electronic address: s.pertega@udc.es., García-Rodríguez T; Instituto de Investigación Biomédica de A Coruña (INIBIC), Nursing and Health Care Research Group, Xubias de Arriba 84, 15006 A Coruña, Spain., González-Martín C; Universidade da Coruña, Rheumatology and Health Research Group, Department of Health Sciences, Faculty of Nursing and Podiatry, Esteiro, 15403 Ferrol, Spain; Instituto de Investigación Biomédica de A Coruña (INIBIC), Nursing and Health Care Research Group, Xubias de Arriba 84, 15006 A Coruña, Spain., Pardeiro-Pértega R; Digestive System Department, Complexo Hospitalario Universitario A Coruña, Xubias de Arriba 84, 15006 A Coruña, Spain., Yáñez-González-Dopeso L; Digestive System Department, Complexo Hospitalario Universitario A Coruña, Xubias de Arriba 84, 15006 A Coruña, Spain., Seoane-Pillado T; Universidade da Coruña, Rheumatology and Health Research Group, Department of Health Sciences, Faculty of Nursing and Podiatry, Esteiro, 15403 Ferrol, Spain; Instituto de Investigación Biomédica de A Coruña (INIBIC), Nursing and Health Care Research Group, Xubias de Arriba 84, 15006 A Coruña, Spain.

المصدر: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2024 Jul; Vol. 56 (7), pp. 1229-1236. Date of Electronic Publication: 2023 Dec 11.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3562 (Electronic) Linking ISSN: 15908658 NLM ISO Abbreviation: Dig Liver Dis Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/surgery , Colorectal Neoplasms*/mortality , Colorectal Neoplasms*/pathology , Neoplasm Recurrence, Local*/epidemiology , Neoplasm Recurrence, Local*/mortality, Humans ; Male ; Aged ; Female ; Middle Aged ; Risk Factors ; Follow-Up Studies ; Prognosis ; Incidence ; Aged, 80 and over ; Neoplasm Staging ; Proportional Hazards Models

المؤلفون: van Opijnen MP; Department of Neurosurgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands. m.p.van_opijnen@lumc.nl.; Department of Cell and Chemical Biology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands. m.p.van_opijnen@lumc.nl., de Vos FYF; Department of Medical Oncology, Utrecht University Medical Center, Utrecht, the Netherlands., Cuppen E; Hartwig Medical Foundation, Amsterdam, the Netherlands.; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands., Geurts M; Departments of Neurology and Medical Oncology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Maas SLN; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Broekman MLD; Department of Neurosurgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.; Department of Cell and Chemical Biology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.; Department of Neurosurgery, Haaglanden Medical Center, Lijnbaan 32, 2512 VA, The Hague, the Netherlands.

المصدر: Medical oncology (Northwood, London, England) [Med Oncol] 2024 Sep 24; Vol. 41 (11), pp. 250. Date of Electronic Publication: 2024 Sep 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/genetics , Glioblastoma*/drug therapy , Glioblastoma*/therapy , Biomarkers, Tumor*/genetics , Neoplasm Recurrence, Local*/genetics , Neoplasm Recurrence, Local*/drug therapy , Brain Neoplasms*/genetics , Brain Neoplasms*/drug therapy , Brain Neoplasms*/therapy , Clinical Trials as Topic*, Humans ; Molecular Targeted Therapy/methods

المؤلفون: Janbain A; European Hospital Georges-Pompidou., Clinical research unit, INSERM Clinical Investigation Center., Paris Cité University, Paris, France., Farolfi A; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Guenegou-Arnoux A; European Hospital Georges-Pompidou., Clinical research unit, INSERM Clinical Investigation Center., Paris Cité University, Paris, France., Romengas L; European Hospital Georges-Pompidou., Clinical research unit, INSERM Clinical Investigation Center., Paris Cité University, Paris, France., Scharl S; Department of Radiation Oncology, University of Ulm, Ulm, Germany., Fanti S; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Serani F; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Peeken JC; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany., Katsahian S; European Hospital Georges-Pompidou., Clinical research unit, INSERM Clinical Investigation Center., Paris Cité University, Paris, France., Strouthos I; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus., Ferentinos K; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus., Koerber SA; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Vogel ME; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany., Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany., Vrachimis A; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus., Morganti AG; Division of Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Spohn SK; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Grosu AL; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Ceci F; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy., Henkenberens C; Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany., Kroeze SG; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland., Guckenberger M; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland., Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Hruby G; Department of Radiation Oncology, Royal North Shore Hospital-University of Sydney, Sydney, Australia., Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Sydney, Australia., Omerieh AA; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Schmidt-Hegemann NS; Department of Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland., Mose L; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Aebersold DM; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Zamboglou C; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus., Wiegel T; Department of Radiation Oncology, University of Ulm, Ulm, Germany., Shelan M; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

المصدر: JMIR cancer [JMIR Cancer] 2024 Sep 20; Vol. 10, pp. e60323. Date of Electronic Publication: 2024 Sep 20.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101666844 Publication Model: Electronic Cited Medium: Internet ISSN: 2369-1999 (Electronic) Linking ISSN: 23691999 NLM ISO Abbreviation: JMIR Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/surgery , Prostatic Neoplasms*/diagnostic imaging , Prostatic Neoplasms*/pathology , Prostatectomy*/methods , Salvage Therapy*/methods , Machine Learning* , Neoplasm Recurrence, Local*/diagnostic imaging , Neoplasm Recurrence, Local*/radiotherapy, Humans ; Male ; Retrospective Studies ; Aged ; Middle Aged ; Positron-Emission Tomography/methods ; Prostate-Specific Antigen/blood ; Antigens, Surface/metabolism ; Glutamate Carboxypeptidase II/metabolism ; Radiotherapy, Image-Guided/methods ; Nomograms

المؤلفون: Hahn E; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Sutradhar R; ICES, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Paszat L; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; ICES, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Nguyen L; ICES, Toronto, ON, Canada., Rodin D; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Nofech-Mozes S; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Trebinjac S; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Jerzak KJ; Department of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Fong C; ICES, Toronto, ON, Canada., Rakovitch E; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; ICES, Toronto, ON, Canada.; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 20; Vol. 42 (27), pp. 3196-3206. Date of Electronic Publication: 2024 Jun 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/surgery , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Mastectomy, Segmental* , Neoplasm Recurrence, Local*/genetics , Neoplasm Recurrence, Local*/pathology , Carcinoma, Intraductal, Noninfiltrating*/surgery , Carcinoma, Intraductal, Noninfiltrating*/pathology , Carcinoma, Intraductal, Noninfiltrating*/genetics, Humans ; Female ; Middle Aged ; Aged ; Radiotherapy, Adjuvant ; Adult ; Neoplasm Invasiveness ; Gene Expression Profiling ; Predictive Value of Tests ; Risk Assessment

المؤلفون: Tang Y; Department of General Surgery, The Third Hospital of MianYang, Sichuan Mental Health Center, MianYang, 621000, China., Fan Y; Department of General Surgery, The Third Hospital of MianYang, Sichuan Mental Health Center, MianYang, 621000, China. fanyaocqykdx@163.com.

المصدر: BMC cancer [BMC Cancer] 2024 Sep 17; Vol. 24 (1), pp. 1155. Date of Electronic Publication: 2024 Sep 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/pathology , Tumor Suppressor Protein p53*/genetics , Proto-Oncogene Proteins p21(ras)*/genetics , Mutation* , Drug Resistance, Neoplasm*/genetics , Neoplasm Recurrence, Local*/genetics , Neoplasm Recurrence, Local*/drug therapy, Humans ; Male ; Female ; Middle Aged ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Neoplasm Metastasis ; Adult

المؤلفون: Guo H; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Malone KE; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Heckbert SR; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Li CI; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.

المصدر: Cancer [Cancer] 2024 Sep 15; Vol. 130 (18), pp. 3106-3114. Date of Electronic Publication: 2024 May 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/mortality , Breast Neoplasms*/pathology , Breast Neoplasms*/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Neoplasm Recurrence, Local*/prevention & control , Neoplasm Recurrence, Local*/epidemiology, Humans ; Female ; Aged ; Retrospective Studies ; Aged, 80 and over ; United States/epidemiology ; SEER Program ; Proportional Hazards Models ; Risk Factors

المؤلفون: Riva HR; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA., Yoon T; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA., Mohammad K Shalabi M; Department of Dermatology, Baylor Scott & White Medical Center, Temple, TX, USA., Hussain A; Galaria Plastic Surgery & Dermatology, Chantilly, VA, USA., Khachemoune A; Department of Dermatology, State University of New York, Downstate Health Sciences University, Brooklyn, NY, USA. Amorkh@gmail.com.

المصدر: Archives of dermatological research [Arch Dermatol Res] 2024 Sep 14; Vol. 316 (9), pp. 617. Date of Electronic Publication: 2024 Sep 14.

نوع المنشور: Systematic Review; Journal Article; Review

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X (Electronic) Linking ISSN: 03403696 NLM ISO Abbreviation: Arch Dermatol Res Subsets: MEDLINE

مواضيع طبية MeSH: Mohs Surgery*/methods , Skin Neoplasms*/surgery , Skin Neoplasms*/virology , Neoplasm Recurrence, Local*/epidemiology , Neoplasm Recurrence, Local*/virology , Papillomavirus Infections*/surgery , Papillomavirus Infections*/complications , Papillomavirus Infections*/virology, Humans ; Carcinoma, Squamous Cell/surgery ; Carcinoma, Squamous Cell/virology ; Carcinoma, Squamous Cell/pathology ; Male ; Treatment Outcome ; Papillomaviridae/isolation & purification ; Bowen's Disease/surgery ; Bowen's Disease/virology ; Human Papillomavirus Viruses

المؤلفون: Grommes C; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Nandakumar S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Schaff LR; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Gavrilovic I; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Kaley TJ; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Nolan CP; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Stone J; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Thomas AA; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Tang SS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Wolfe J; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Bozza A; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Wongchai V; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Hyde A; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Barrett E; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Lynch EA; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Madzsar JT; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Lin A; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Piotrowski AF; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Pentsova E; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Francis JH; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Hatzoglou V; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Schultz N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Reiner AS; Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Panageas KS; Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., DeAngelis LM; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Mellinghoff IK; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 13; Vol. 30 (18), pp. 4005-4015.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Adenine*/analogs & derivatives , Adenine*/therapeutic use , Piperidines*/therapeutic use , Central Nervous System Neoplasms*/drug therapy , Central Nervous System Neoplasms*/secondary , Central Nervous System Neoplasms*/mortality , Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/pathology, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Drug Resistance, Neoplasm ; Lymphoma/drug therapy ; Lymphoma/mortality ; Lymphoma/pathology ; Pyrazoles/therapeutic use ; Pyrazoles/administration & dosage ; Pyrazoles/adverse effects ; Pyrimidines/therapeutic use ; Pyrimidines/administration & dosage ; Pyrimidines/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/administration & dosage ; Treatment Outcome ; Agammaglobulinaemia Tyrosine Kinase/antagonists & inhibitors ; Agammaglobulinaemia Tyrosine Kinase/genetics ; Mutation

المؤلفون: Lv CB; Zhangzhou Affiliated Hospital of Fujian Medical University'sDepartment of Gastric Surgery, No.59 Sheng-li Road, Zhangzhou City, Fujian Province, China., Tong LY; Zhangzhou Affiliated Hospital of Fujian Medical University'sDepartment of Gastric Surgery, No.59 Sheng-li Road, Zhangzhou City, Fujian Province, China., Zeng WM; Zhangzhou Affiliated Hospital of Fujian Medical University'sDepartment of Gastric Surgery, No.59 Sheng-li Road, Zhangzhou City, Fujian Province, China., Chen QX; Zhangzhou Affiliated Hospital of Fujian Medical University'sDepartment of Gastric Surgery, No.59 Sheng-li Road, Zhangzhou City, Fujian Province, China., Fang SY; Zhangzhou Affiliated Hospital of Fujian Medical University'sDepartment of Gastric Surgery, No.59 Sheng-li Road, Zhangzhou City, Fujian Province, China., Sun YQ; Zhangzhou Affiliated Hospital of Fujian Medical University'sDepartment of Gastric Surgery, No.59 Sheng-li Road, Zhangzhou City, Fujian Province, China., Cai LS; Department of Ultrasound, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou City, Fujian Province, China. cailishengcls@163.com.

المصدر: World journal of surgical oncology [World J Surg Oncol] 2024 Sep 11; Vol. 22 (1), pp. 244. Date of Electronic Publication: 2024 Sep 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819 (Electronic) Linking ISSN: 14777819 NLM ISO Abbreviation: World J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/pathology , Stomach Neoplasms*/therapy , Stomach Neoplasms*/surgery , Stomach Neoplasms*/mortality , Gastrectomy*/methods , Propensity Score* , Laparoscopy*/methods , Neoadjuvant Therapy*/methods , Hyperthermic Intraperitoneal Chemotherapy*/methods , Neoplasm Recurrence, Local*/prevention & control , Neoplasm Recurrence, Local*/pathology , Neoplasm Recurrence, Local*/therapy, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Survival Rate ; Prognosis ; Follow-Up Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Neoplasm Staging ; Combined Modality Therapy ; Aged ; Chemotherapy, Adjuvant/methods ; Peritoneal Neoplasms/therapy ; Peritoneal Neoplasms/secondary ; Peritoneal Neoplasms/mortality ; Adult